3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
10
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Topotecan
×
90 days
×
Clear all
No trials found.